16-15708830-G-T
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_001040113.2(MYH11):c.5819C>A(p.Pro1940Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00164 in 1,605,908 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1940L) has been classified as Likely benign.
Frequency
Consequence
NM_001040113.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH11 | NM_001040113.2 | c.5819C>A | p.Pro1940Gln | missense_variant | 42/43 | ENST00000452625.7 | NP_001035202.1 | |
MYH11 | NM_002474.3 | c.5787-4707C>A | intron_variant | ENST00000300036.6 | NP_002465.1 | |||
NDE1 | NM_017668.3 | c.947+11970G>T | intron_variant | ENST00000396354.6 | NP_060138.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH11 | ENST00000452625.7 | c.5819C>A | p.Pro1940Gln | missense_variant | 42/43 | 1 | NM_001040113.2 | ENSP00000407821.2 | ||
MYH11 | ENST00000300036.6 | c.5787-4707C>A | intron_variant | 1 | NM_002474.3 | ENSP00000300036.5 | ||||
NDE1 | ENST00000396354.6 | c.947+11970G>T | intron_variant | 1 | NM_017668.3 | ENSP00000379642.1 |
Frequencies
GnomAD3 genomes AF: 0.00330 AC: 501AN: 151720Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.00133 AC: 311AN: 233460Hom.: 1 AF XY: 0.00117 AC XY: 148AN XY: 126162
GnomAD4 exome AF: 0.00147 AC: 2132AN: 1454070Hom.: 0 Cov.: 32 AF XY: 0.00141 AC XY: 1021AN XY: 722608
GnomAD4 genome AF: 0.00331 AC: 503AN: 151838Hom.: 4 Cov.: 33 AF XY: 0.00327 AC XY: 243AN XY: 74236
ClinVar
Submissions by phenotype
not provided Benign:5
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2024 | MYH11: BP4, BS2; NDE1: BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 07, 2023 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 25, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 11, 2018 | Variant summary: MYH11 c.5819C>A (p.Pro1940Gln) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0015 in 259712 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 1229-folds higher than the estimated maximal expected allele frequency for a pathogenic variant in MYH11 causing Aortopathy phenotype (1.3e-06), strongly suggesting that the variant is benign. Yeung_2017 reports the variant in one patient with aortic aneurysm (AA) and following an evaluation of the effect of the variant on RNA splicing concluded that transcripts containing exon 42 are not expressed in smooth muscle cell (SMC)-like cells or primary SMC and therefore, the variant c.5819C>A in MYH11 is not pathogenic and variants in exon 42 are not relevant for familial thoracic AA. Three ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cite the variant twice as benign and once as uncertain significance. Based on the evidence outlined above, the variant was classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Aortic aneurysm, familial thoracic 4 Uncertain:1Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Mar 30, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Familial thoracic aortic aneurysm and aortic dissection Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Mar 07, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | May 10, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at